Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New amidines synthesized at Astra are selective inhibitors of nNOS

Jan. 27, 1999

Pharmacia & Upjohn's antiparkinsonian approved in Spain

Jan. 26, 1999

BTG enters agreement with Novo Nordisk for pain and epilepsy compounds

Jan. 26, 1999

More 5-HT4 receptor ligands in development at Synthelabo

Jan. 26, 1999

Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D

Jan. 26, 1999

L-754030 will enter phase III testing for emesis

Jan. 25, 1999

Preparation and use of neuronal NOS inhibitors disclosed by Astra

Jan. 25, 1999

New 5-HT4 receptor ligands from Synthelabo, their synthesis and use

Jan. 25, 1999

Neurotransmitter reuptake-inhibitory piperidines designed at NeuroSearch

Jan. 25, 1999

Several setbacks reported with Lundbeck antipsychotic

Jan. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...